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BACKGROUND 
● Lower extremity peripheral arterial disease (PAD) is primarily caused by 
atherosclerosis and thromboembolic processes that alter the normal 
function of the arteries of lower extremities.  
● Acute limb ischemia (ALI) is a type of PAD that arises with sudden 
decrease in reperfusion that threatens the tissue viability and often 
associated with thrombosis due to plaque rupture, thrombosis of lower 
extremity bypass graft, or embolism originating from the heart or proximal 
arterial aneurysm.1  
● In cases of acute limb ischemia due to arterial emboli or thrombosis, 
immediate treatment with unfractionated heparin should be given. The 
expert panel suggests reperfusion therapy (surgery vs intraarterial (IA) 
thrombolysis), although surgery is recommended over IA thrombolysis.1  
● Once ALI is suspected, timely clinical evaluation is needed in order to 
make decisions on treatment. 
● Surgical revascularization, such as bypass graft, is indicated in patients 
with limb ischemia without adequate improvement by exercise 
rehabilitation, pharmacologic therapy, and significant limitations of daily 
activities.  
● Bypass graft occlusion may result due to various reasons such as: 
○ Technical complications of the graft 
○ Thrombosis due to inadequate outflow of blood 
○ Myointimal hyperplasia 
○ Progression of atherosclerosis 
● Results of prospective, randomized trial demonstrated that thrombolysis in 
acutely ischemic (<14 days) improved limb salvage and reduced the 
magnitude of the surgical procedure.2  
● Studies demonstrated 57% success rate with streptokinase, whereas 
almost 90% of grafts have been successfully opened with tPA in other 
studies.3 
● If patency of the occlusion is not restored, patient will have to be 
reassessed for surgical revascularization and possible amputation. 
 
● Patient is a 58 year old male who presented to an outpatient clinic for 
evaluation due to complaints of severe right leg pain unable to be 
controlled by his pain medications. 
● He has a past medical history significant for PAD requiring right popliteal-
to-posterior tibial artery bypass two weeks prior to admission. 
● Patient also complains of tingling in his right foot, in which the duplex 
ultrasound demonstrated occlusion of the right lower extremity bypass 
graft. 
● He was subsequently admitted to a general medical and surgical hospital 
with 250 beds for restoring patency of the bypass graft. 
● Upon presentation for evaluation, it was also noted that the incision on his 
right thigh was intact and dry; however, the incision on his calf had mild 
separation with some sero-sanguineous drainage.  
● Based upon the patient’s arterial graft thrombosis and need for urgent 
revascularization, as well as possible presence of infectious process, the 
patient was admitted to intensive care unit and was initiated on both 
therapeutic alteplase and heparin infusions. 
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SUMMARY OF EVENTS 
Days (D) of hospitalization 
D1 • Patient presents to the outpatient clinic with complains of severe pain and tingling in his right leg two 
weeks after popliteal-to-posterior tibial artery bypass 
• Dx: Occlusion of right femoropopliteal bypass graft 
• Admitted to cardiovascular intensive care unit and started on alteplase and heparin infusions 
D2 • Continued to infuse tPA and Heparin drip 
• RLE incision with superficial abrasion and opening along surgical incision 
D3 • Continued to infuse tPA and heparin drip 
• Right foot cool, toes cyanotic with non-healing ulcerations, sensation intact 
D4 • Angiogram performed and revealed patency of patient’s bypass graft 
• Alteplase and heparin infusions were discontinued. 
• Foot pink and warm post discontinuation of lysis 
• 5th toe ulcer with necrotic toe tips x2 
• Posterior tibial artery 2+ palpitation pulse 
D5 • Reocclusion of right popliteal-to-posterior byass - 3rd and 5th toes dusky 
• Patient had hypotension which appears to be related to a recent non-ST-elevated myocardial infarction 
(NSTEMI) 
• No plan for reintervention of RLE at present due to NSTEMI 
D6 • Echocardiogram confirmed acute changes in left ventricular ejection fraction with increase in troponin 
• Left heart catheterization performed 
• Heparin continuous infusion started 
• No plan for reintervention for RLE at present 
D7 • Underwent coronary arterial bypass graft (CABG) w/ endoscopic vessel harvest (EVH) of saphenous vein 
• At the time of surgery, patient found to have calcific atherosclerosis of below-knee popliteal artery 
• Continued heparin continuous infusion 
• No plan for revascularization for RLE at present 
D37 • Patient returned to the hospital with developed dry gangrene on right 2nd, 3rd, and 5th toes 
D42 • Right trans-metatarsal amputation on all 5 toes. 
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Because peripheral arterial disease is primarily caused by atherosclerosis and thromboembolic processes, all 
patients undergoing revascularization should be placed on antiplatelet therapy indefinitely to reduce the risk of MI, 
stroke, and vascular death, unless contraindicated. ACC/AHA recommends aspirin 75 to 325 mg to be safe and 
effective to reduce the risks.1,5 Clopidogrel 75 mg is considered to be safe and effective as an alternative to 
aspirin.1,5 All patients should be placed on a high-potency statin therapy, such as atorvastatin and rosuvastatin, as 
PAD is a type of ASCVD.6  Antihypertensive therapy should be administered to patients with hypertension to reduce 
the risk of MI, stroke, CHF, and cardiovascular death.5 Glycemic control should be maintained to reduce 
microvascular complications and improve cardiovascular outcomes.5 If the patient is a smoker, should ask the 
patient about smoking status at each session and assist with counseling and developing a plan for quitting that may 
include pharmacotherapy.1 
 
Long-term patency of bypass grafts should be evaluated for at least 2 years using resting ankle-brachial index (ABI), 
physical exam, and a duplex ultrasound at regular intervals.1 
 
For patients who have severe PAD with a viable or salvageable limb, the ACC/AHA PAD guideline recommends 
initial management with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) followed by catheter-
based thrombolysis over surgical revascularization for occlusion of peripheral arteries based on trials that included 
occlusion of native arteries and bypass grafts.1 
However, there is not specific management for peripheral arterial bypass graft occlusion available. More studies that 
focus specifically on peripheral bypass occlusions are needed to improve prevention, management, and monitoring 
after revascularization. 
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